Application Number: 10-2021-0006947
Title of Invention: Pharmaceutical composition for treating TRPV1 activation-mediated diseases
With the aprobación of this nacional patent, RudaCure Inc. has taken one step closer to commercializing RCI002 for various pain conditions.
La empresa planea continuar expanding its patent portfolio in line with its patent strategy as it secures additional pipelines in the future.